AURORA CANNABIS INC
AURORA CANNABIS INC is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $177.8M market cap.
Most recent earnings call: Q1 FY26 on Aug 6, 2025.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks ACB's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters but stock falls 60% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ACB.
$ curl https://api.spokenalpha.com/v1/companies/ACBFAQ
Spoken Alpha indexes ACB's earnings call transcripts at https://spokenalpha.com/companies/ACB. Each call links to attributed speakers and parsed analyst Q&A. AURORA CANNABIS INC's own investor relations page is at https://www.auroramj.com/investors/quarterly-reports/.
AURORA CANNABIS INC (ACB) held its most recent earnings call on 2025-08-06, covering fiscal Q1 2026.
AURORA CANNABIS INC (ACB) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.59 | $0.57 | +4.3% | -1.4% | -1.6% |
| Q4 FY2026 | $0.41 | $0.39 | +4.0% | -2.0% | -2.3% |
| Q3 FY2026 | $0.61 | $0.61 | -0.6% | -2.3% | -3.5% |
| Q2 FY2026 | $0.47 | $0.49 | -3.1% | +0.3% | -1.0% |
| Q1 FY2025 | $0.49 | $0.49 | -0.8% | +1.2% | +0.7% |
| Q4 FY2025 |
| $0.70 |
| $0.68 |
| +3.4% |
| +3.4% |
| +3.2% |
| Q3 FY2025 | $0.62 | $0.57 | +9.4% | -2.3% | -0.6% |
| Q2 FY2025 | $0.60 | $0.54 | +12.0% | -3.5% | -0.6% |
| Q1 FY2024 | $0.80 | $0.79 | +1.7% | +3.6% | +5.5% |
| Q4 FY2024 | $0.61 | $0.56 | +8.1% | -1.4% | +1.4% |